Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 1
Submit an article Journal homepage
49
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Angioimmunoblastic Lymphadenopathy (AILD) May Respond to Thalidomide Treatment: Two Case Reports

C. Strupp Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany
,
M. Aivado Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany
,
U. Germing Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany
,
N. Gattermann Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany
&
R. Haas Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany
Pages 133-137 | Published online: 01 Jul 2009

  • Foerster, G. and Moeschlins, S. (1954) "Extramedulläres plasmozytom mit dysproteinämie und erworbener hämolytischer anämie", Schweiz. Med. Wochenschr. 84, 1106-1110.
  • Schauer, P.K., Straus, D.J., Bagley, Jr., C.M., Rudolph, R.H., McCracken, J.D., Huff, J., Glucksburg, H., Bauermeister, D.E. and Clarkson, B.D. (1981) "Angioimmunoblastic lymphadenopathy: clinical spectrum of disease", cancer 48, 2493-2498.
  • Smith, J.L., Hodges, E., Quin, C.T., McCarthy, K.P. and Wright, D.H. (2000) "Frequent T and B cell oligoclones in histologically and immunopheotypically characterized angioimmunoblastic lymphadenopathy", Am. J. Pathol. 156, 661-669.
  • Gerklando, Q., Barbera, V., Ammatuna, Franco, V., Florena, A.M. and Mariani, G. (2000) "Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone", Haematologica 85, 880-881.
  • Pautier, P., Devidas, A., Delmer, A., Dombret, H., Sutton, L., Zini, J.M., Nedelec, G., Molina, T., Marroleau, J.P. and Brice, P. (1999) "Angioimmunoblastic-like T-cell non-Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature", Leuk, Lymph. 32, 545-552.
  • Siegert, W., Agthe, A., Griesser, H., Scnwerdtfeger, R., Brittinger. G., Engelhard, M., Kuse, R., Tiemann, M., Lennert, K. and Huhn, D. (1992) "Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP16 regimen", Ann. Intern. Med. 117, 364-370.
  • Takemori, N., Kodaira, J., Toyoshima, N., Sato. T., Sakurai, H., Akakura, N., Kimura, S. and Katagiri, M. (1999) "Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A", Leuk. Lymph. 35, 389-395.
  • Yamamura, M., Honda, M., Yamada, Y., ltomaya, T., Sohda, H., Yubashi, T., Momita, S., Karnihira, S., Ohmoto, Y. and Tomogana, M. (1996) "Increased levels of interieukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lympha- denopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A", Leukemia 10, 1504-1508.
  • Siegert, W., Nerl, C., Meuthen, I., Zahn, T., Brack, N., Lennert, K. and Huhn, D. (1991) "Recombinant human interferon a in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients". Leukemia 5, 892-895.
  • Bourgeois, E., Auxenfants, E., Jouffrey, C., Dubest, C., Mahieu, M. and Rose, C. (2000) "Efficiacy of fludarabine in the treatment of angioimmunoblastic lymphoma (AIL)", Ann. Med. Interne. (Paris) 151, 230-231.
  • Hast, R., Jacobsson, B., Petrescu, A. and Hjalmar, V. (1999) "Successful treatment with fludarabine in two cases of.angioimmunoblastic lymphadenopathy with dysproteinemia", Leuk. Lymph. 34, 597-601.
  • Sallah, A.S. and Bernard, S. (1996) 'Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine", Ann. Hematol. 73, 295-296.
  • Lindahl, J., Kimby, E., Bjorkstrand, B., Christensson, B. and Hellstrom-Liodberg, E. (2001) "High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD", Leuk. Res. 25, 267-270.
  • Ribatti, D., Vacca, A., Nico, B., Fanelli, M., Roncali, L. and Dammacco, F (1996) "Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymaphomas. An immunohistochemical and ultrastructural study". Eur. J. Haematol. 56, 45-53.
  • Vacca, A., Ribatti, D., Roncali, L. and Dammacco, F. (1995) "Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies". Leuk. Lymph. 20, 27-38.
  • Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. and Stein, H. (1997) "Expression of vascular endothelial growth factor in lymphomas and Castletman's disease". J. Pathol. 183, 44-50.
  • Salven, P., Teerenhovi, L. and Joensuu, H. (1997) "A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma". Blood 90, 3167-3172.
  • Ohhima, K., Haraoka, S., Suzumiya, J., Kawasaki, C., Kanda, M. and Kikuchi, M. (2000) "Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia", Leuk. Lymph. 38, 541-545.
  • Yamaguchi, S., Kitagawa, M., Inoue, M., Tomizawa, N., Kamiyama, R. and Hirokawa, K. (2000) "Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma". Exp. Mol. Pathol. 68, 85-94.
  • D' Amato, R.J., Loughnan, M.S., Flynn, E. and Folkman, J. (1994) "Thalidomide is an inhibitor of angiogenesis", Proc, Natl. Acad. Sci. USA 91, 4082-4085.
  • Bauer, K.S., Dixon, S.C. and Figg, W.D. (1998) "Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent", Biochem. Pharmacol. 55, 1827-1834.
  • Rowland, T.L., McHugh, S.M., Deighton, J., Ewan, P.W., Dearman, R.J. and Kimber, I. (1999) "Selective down-regulation of T cell-and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone", Immuntol. Lett. 68, 325-332.
  • Nogueira, A., Neubert, R., Helge, H. and Neubert, D. (1994) "Thalidomide and the immune system 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells", Life Sci. 55, 77-92.
  • Flageul, B., Wallach, D., Cavelier-Balloy, B., Bachelez, H., Carsuzaa, F. and Dubertret, L. (2000) "Thalidomide and thrombosis", Ann. Dermatol. Venereal. 127, 171-174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.